122 related articles for article (PubMed ID: 3750375)
21. Noninvasive follow-up of platinum pharmacokinetics in the skin of patients on cisplatin chemotherapy.
Gorodetsky R; Mou X; Vexler A; Kaufman B; Catane R; Loewenthal E
Cancer; 1993 Jul; 72(2):446-54. PubMed ID: 8319176
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of cis-dichlorodiammineplatinum.
Gormley PE; Bull JM; LeRoy AF; Cysyk R
Clin Pharmacol Ther; 1979 Mar; 25(3):351-7. PubMed ID: 761445
[TBL] [Abstract][Full Text] [Related]
23. Determination of platinum traces contamination by graphite furnace atomic absorption spectrometry after preconcentration by cloud point extraction.
Chappuy M; Caudron E; Bellanger A; Pradeau D
J Hazard Mater; 2010 Apr; 176(1-3):207-12. PubMed ID: 19962825
[TBL] [Abstract][Full Text] [Related]
24. Analysis of enloplatin by liquid chromatography and of platinum by atomic absorption spectrometry in various biological fluids.
Amorusi P; Lessard D; Bansal SK; Selinger K; Yacobi A; Tonelli AP
J Pharm Biomed Anal; 1994 Aug; 12(8):1023-33. PubMed ID: 7819376
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of inductively coupled mass spectrometry for the determination of platinum in plasma.
Allain P; Berre S; Mauras Y; Le Bouil A
Biol Mass Spectrom; 1992 Mar; 21(3):141-3. PubMed ID: 1576172
[TBL] [Abstract][Full Text] [Related]
26. Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin.
Reece PA; Stafford I; Russell J; Gill PG
J Clin Oncol; 1986 Sep; 4(9):1392-8. PubMed ID: 3746376
[TBL] [Abstract][Full Text] [Related]
27. Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
Motzer RJ; Reed E; Perera F; Tang D; Shamkhani H; Poirier MC; Tsai WY; Parker RJ; Bosl GJ
Cancer; 1994 Jun; 73(11):2843-52. PubMed ID: 7514956
[TBL] [Abstract][Full Text] [Related]
28. Determination of platinum, palladium, and lead in biological samples by atomic absorption spectrophotometry.
Tillery JB; Johnson DE
Environ Health Perspect; 1975 Dec; 12():19-26. PubMed ID: 1227857
[TBL] [Abstract][Full Text] [Related]
29. Influence of frusemide on cis-dichlorodiammineplatinum (II) pharmaco-kinetics.
Dumas M; d'Athis P; de Gislain C; Lautissier JL; Autissier N; Escousse A; Guerrin J
Eur J Drug Metab Pharmacokinet; 1987; 12(3):203-6. PubMed ID: 3436343
[TBL] [Abstract][Full Text] [Related]
30. High performance liquid chromatographic determination of platinum in blood and urine samples of cancer patients after administration of cisplatin drug using solvent extraction and N,N'-bis(salicylidene)-1,2-propanediamine as complexation reagent.
Lanjwani SN; Zhu R; Khuhawar MY; Ding Z
J Pharm Biomed Anal; 2006 Mar; 40(4):833-9. PubMed ID: 16181764
[TBL] [Abstract][Full Text] [Related]
31. Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancer.
Erlichman C; Soldin SJ; Thiessen JJ; Sturgeon JF; Fine S
Cancer Chemother Pharmacol; 1987; 19(1):75-9. PubMed ID: 3815729
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
Fracasso ME; Apostoli P; Benoni G; Bonetti A; Griso C; Leone R
Drugs Exp Clin Res; 1987; 13(6):367-72. PubMed ID: 3652926
[TBL] [Abstract][Full Text] [Related]
33. [Platinum concentrations in human tissue after administration of cisplatin].
Tochigi T; Ono K; Yoshikawa K; Hoshi S; Orikasa S; Imai Y
Gan To Kagaku Ryoho; 1988 Feb; 15(2):269-75. PubMed ID: 3341789
[TBL] [Abstract][Full Text] [Related]
34. Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II).
Dumas M; d'Athis P; de Gislain C; Escousse A; Guerrin J; Autissier N
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):430-3. PubMed ID: 4044076
[TBL] [Abstract][Full Text] [Related]
35. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
[TBL] [Abstract][Full Text] [Related]
36. Determination of platinum in urine, ultrafiltrate, and whole plasma by isotope dilution gas chromatography-mass spectrometry compared to electrothermal atomic absorption spectrometry.
Aggarwal SK; Gemma NW; Kinter M; Nicholson J; Shipe JR; Herold DA
Anal Biochem; 1993 Apr; 210(1):113-8. PubMed ID: 8489005
[TBL] [Abstract][Full Text] [Related]
37. Determination of platinum and palladium in blood and urine by flameless atomic absorption spectrophotometry.
Jones AH
Anal Chem; 1976 Sep; 48(11):1472-4. PubMed ID: 962142
[No Abstract] [Full Text] [Related]
38. Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity.
Stewart DJ; Mikhael NZ; Nanji AA; Nair RC; Kacew S; Howard K; Hirte W; Maroun JA
J Clin Oncol; 1985 Sep; 3(9):1251-6. PubMed ID: 4040958
[TBL] [Abstract][Full Text] [Related]
39. Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.
DeGregorio M; Wilbur B; King O; Wallenberg J; Prewitt S; Phillips J; Wilbur J
Cancer Treat Rep; 1986 Dec; 70(12):1437-8. PubMed ID: 3791256
[TBL] [Abstract][Full Text] [Related]
40. Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry.
Milacic R; Cemazar M; Sersa G
J Pharm Biomed Anal; 1997 Oct; 16(2):343-8. PubMed ID: 9408853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
